Phase 1b/2 Study of Selinexor (KPT-330) in Combination w/ Backbone Treatments for Relapsed/Refractory Multiple Myeloma (STOMP)

This trial is open and accepting eligible patients.

Trial Overview

This study will independently assess the efficacy and safety of three combination therapies for the treatment of patients with relapsed/refractory multiple myeloma (RR MM): selinexor + dexamethasone + pomalidomide (SdP) and selinexor + dexamethasone + bortezomib (SdB), selinexor + dexamtheasone + lenalidomide.


What is the phase of this trial?

Phase 1/2 what does this mean

What type of trial is this?

This is an interventional trial. This type of trial actively treats your myeloma.

What treatments are used in this trial?
Trial Locations

There are 4 trial sites around the United States.
Find the closest trial site.

How many patients will participate in this trial?

Approximately 140 patients will be enrolled in this study.

Who is sponsoring this trial?

Karyopharm Therapeutics

SparkCures Trial Identifiers

MM-0738 , NCT02343042 what is this

4 US locations

Am I Eligible For This Trial?

All clinical trials provide reasons that patients may or may not be able to join called 'eligibility criteria'. The following is a high-level eligibility criteria provided by the sponsor of this trial. Additional eligibility criteria may apply.

As a patient, what should I expect?

Trial Contact Information

Trial locations are sorted by state. Enter your zip code to sort by closest distance.

California

UCLA Jonsson Comprehensive Cancer Center

(University of California Los Angeles)

10833 Le Conte Avenue, Los Angeles, CA 90024

This site is open and accepting eligible patients.


Connect with Study Site  

New York

Herbert Irving Comprehensive Cancer Center

(Columbia University Medical Center)

1130 St Nicholas Avenue, New York, NY 10032

This site is open and accepting eligible patients.


Connect with Study Site  

North Carolina

Duke Cancer Center

(Duke University Medical Center)

20 Duke Medicine Circle, Durham, NC 27710

This site is open and accepting eligible patients.


Connect with Study Site  

Washington

Swedish Cancer Institute

(Cherry Hill Campus)

500 17th Avenue, Seattle, WA 98122

This site is open and accepting eligible patients.


Connect with Study Site  

There are 4 active US locations.